ABOUT THIS EVENT

Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, rang the Nasdaq Closing Bell remotely from across the world. 

In honor of the occasion, Lloyd Segal, President and Chief Executive Officer of Repare Therapeutics, rang the Closing Bell alongside Repare’s team in a virtual bell ringing ceremony.